Novo Nordisk Earnings Continue to Surge on Blockbuster Weight-Loss Drug Demand

Novo Nordisk is gradually expanding supply capacity for its blockbuster weight-loss drug, but said it will continue to limit supply of lower-strength doses of the Wegovy medicine in the U.S. as it …